Cargando…

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis

Detalles Bibliográficos
Autores principales: Pelfrene, Eric, Harvey Allchurch, Martin, Ntamabyaliro, Nsengi, Nambasa, Victoria, Ventura, Fátima V., Nagercoil, Nithyanandan, Cavaleri, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597029/
https://www.ncbi.nlm.nih.gov/pubmed/31246956
http://dx.doi.org/10.1371/journal.pntd.0007381
_version_ 1783430532786290688
author Pelfrene, Eric
Harvey Allchurch, Martin
Ntamabyaliro, Nsengi
Nambasa, Victoria
Ventura, Fátima V.
Nagercoil, Nithyanandan
Cavaleri, Marco
author_facet Pelfrene, Eric
Harvey Allchurch, Martin
Ntamabyaliro, Nsengi
Nambasa, Victoria
Ventura, Fátima V.
Nagercoil, Nithyanandan
Cavaleri, Marco
author_sort Pelfrene, Eric
collection PubMed
description
format Online
Article
Text
id pubmed-6597029
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65970292019-07-05 The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis Pelfrene, Eric Harvey Allchurch, Martin Ntamabyaliro, Nsengi Nambasa, Victoria Ventura, Fátima V. Nagercoil, Nithyanandan Cavaleri, Marco PLoS Negl Trop Dis From Innovation to Application Public Library of Science 2019-06-27 /pmc/articles/PMC6597029/ /pubmed/31246956 http://dx.doi.org/10.1371/journal.pntd.0007381 Text en © 2019 Pelfrene et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle From Innovation to Application
Pelfrene, Eric
Harvey Allchurch, Martin
Ntamabyaliro, Nsengi
Nambasa, Victoria
Ventura, Fátima V.
Nagercoil, Nithyanandan
Cavaleri, Marco
The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
title The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
title_full The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
title_fullStr The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
title_full_unstemmed The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
title_short The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
title_sort european medicines agency’s scientific opinion on oral fexinidazole for human african trypanosomiasis
topic From Innovation to Application
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597029/
https://www.ncbi.nlm.nih.gov/pubmed/31246956
http://dx.doi.org/10.1371/journal.pntd.0007381
work_keys_str_mv AT pelfreneeric theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT harveyallchurchmartin theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT ntamabyalironsengi theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT nambasavictoria theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT venturafatimav theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT nagercoilnithyanandan theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT cavalerimarco theeuropeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT pelfreneeric europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT harveyallchurchmartin europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT ntamabyalironsengi europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT nambasavictoria europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT venturafatimav europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT nagercoilnithyanandan europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis
AT cavalerimarco europeanmedicinesagencysscientificopiniononoralfexinidazoleforhumanafricantrypanosomiasis